芬太尼走私
Search documents
欧洲机构分析确认中国芬太尼走私组织在日据点
日经中文网· 2025-08-11 03:04
Core Viewpoint - Bellingcat's analysis indicates that a Chinese fentanyl smuggling organization has established a base in Japan, specifically in Nagoya, suggesting a connection between Japanese entities and Chinese drug networks [2][4][5]. Group 1 - Bellingcat found evidence that the Japanese corporation and the Chinese organization are part of the same international drug network, essentially operating as the same entity [4]. - The Japanese entity, FIRSKY Co., Ltd., was registered in Nagoya and is linked to activities involving the distribution and financial management of dangerous drugs [4][5]. - The investigation corroborates previous reports about the presence of Chinese organizations in Japan [5]. Group 2 - A Chinese chemical company from Wuhan, previously central to the organization, was prosecuted by the U.S., and its female executive was involved in establishing multiple websites related to the organization and FIRSKY [6]. - Data leaked to the dark web revealed that the Chinese organization and FIRSKY used similar methods for the illicit sale of dangerous drugs [6]. - Despite Japan's Finance Minister stating that no illegal fentanyl exports or imports were detected from 2018 to 2024, there have been instances of fentanyl precursor materials found in shipments to Japan from Mexico [6]. Group 3 - The U.S. Ambassador to Japan emphasized the importance of cooperation to prevent the transit and circulation of precursor substances through Japan, aiming to protect regional communities [6]. - The United Nations Office on Drugs and Crime (UNODC) is discussing the establishment of a working group involving Japan and other Asian countries to combat fentanyl smuggling [6]. - Bellingcat is recognized as a leader in open-source intelligence (OSINT) analysis, having recently published exclusive information regarding various global issues [6].
追踪中国芬太尼的日本地下通道(下)
日经中文网· 2025-07-10 02:36
Core Viewpoint - The article discusses the changing dynamics of the Chinese community in Japan, particularly focusing on the case of Xia Fengzhi and his company FIRSKY, which is suspected of being involved in fentanyl trafficking, highlighting the challenges and risks faced by Chinese entrepreneurs in Japan [1][12][18]. Group 1: Background of Chinese Community in Japan - Historically, Japan was a desirable destination for affluent Chinese expatriates, initially attracting mainly academics and professionals [1][13]. - The Chinese population in Japan has significantly increased, with over 800,000 residents as of June 2024, quadrupling over the past 30 years due to relaxed visa policies aimed at promoting foreign entrepreneurship [14]. Group 2: Key Individuals and Their Roles - Jin Dayi, president of the Central Japan Chinese Association, has been instrumental in supporting the local Chinese community for nearly 25 years, providing resources for those looking to learn Japanese and Toyota production techniques [3][4]. - Xia Fengzhi, a 50-year-old entrepreneur, aims to enter the battery business in Japan, leveraging the growing trend of electric vehicles in China [4][12]. Group 3: FIRSKY and Its Operations - FIRSKY, established in Naha in June 2021 and later moved to Nagoya, claims to be a Japanese company but has no mention of battery-related activities in its registration documents [5][11]. - The company is linked to Hubei Amarvel Biotech, which has been implicated in fentanyl trafficking, raising concerns about its true operations [12][16]. Group 4: Legal and Criminal Implications - FIRSKY is suspected of being a base for fentanyl trafficking networks, with connections to Chinese drug cartels operating through Japanese ports [16][17]. - Despite the lack of reported fentanyl-related incidents in Japan, the situation is becoming increasingly urgent, prompting scrutiny from U.S. authorities [16][17]. Group 5: Community Reactions and Lessons Learned - Jin Dayi expressed regret over being deceived by Xia, highlighting the complexities and risks of trusting individuals within the same community [18][19]. - The article serves as a cautionary tale about the potential pitfalls faced by Chinese entrepreneurs in Japan, emphasizing the need for vigilance and due diligence [18].
追踪中国芬太尼的日本地下通道(中)
日经中文网· 2025-07-09 02:44
Core Viewpoint - The article discusses the case of Chen Yiyi, a former executive of Hubei Amarvel Biotech, who was involved in an international drug trafficking operation, specifically related to fentanyl, and highlights the complexities of the organization behind it, including connections to Japan and a figure named Fengzhi Xia [1][8][26]. Group 1: Company Involvement - Hubei Amarvel Biotech was implicated in the illegal export of fentanyl precursors to the United States, playing a crucial role in the drug trafficking network [8][10]. - The company utilized various online platforms to sell dangerous drugs, employing at least 10 sales personnel who communicated in multiple languages to promote their illegal products [10][12]. - The organization employed sophisticated methods to disguise shipments, including altering labels to make them appear as legitimate goods, thus evading customs inspections [12][13]. Group 2: Key Individuals - Chen Yiyi served as a translator for her superior Wang Qingzhou and was responsible for designing the illegal drug sales website [3][8]. - Wang Qingzhou and Chen Yiyi were arrested in Fiji and charged with illegally exporting fentanyl precursors to the U.S. [3][8]. - Fengzhi Xia, identified as a key figure in the operation, was linked to multiple companies in China and was believed to be orchestrating the drug trafficking activities from Japan [15][18][22]. Group 3: Operational Tactics - The organization maintained a complex web of companies across Japan, China, and the U.S. to facilitate drug trafficking while avoiding detection [14][16]. - They promised a high success rate for shipments passing through U.S. customs, indicating a well-planned operation with multiple transit points [13][17]. - The use of Japan as a base for operations was strategic, leveraging the country's reputation for quality and lower scrutiny regarding drug-related crimes [22][23]. Group 4: Legal Proceedings - In January 2025, a jury found Chen Yiyi and others guilty, marking a significant legal action against the fentanyl trafficking network [8][25]. - Chen Yiyi's testimony revealed critical information about the organization, including the identity of the Japanese boss, which may have been an act of self-preservation [26].